Keswani Sanjay Chandru

Keswani Sanjay Chandru is listed in filings as Chief Medical Officer at Neurocrine Biosciences Inc. This profile follows SEC Form 4 activity through Jun 4, 2026, including 6 public disclosures. Recent filings connect the profile to Neurocrine Biosciences Inc (NBIX). The current snapshot covers public activity from Jun 4, 2025 to Jun 4, 2026. Reported amounts are shown as $268.3K to $8.7M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.